This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Pennsylvania. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Colin Greineder: Innovator in Red Blood Cell Targeting Technologies
Introduction
Colin Greineder is a prominent inventor based in Philadelphia, PA. He has made significant contributions to the field of biomedical research, particularly in the area of red blood cell targeting technologies. His innovative work has the potential to impact various medical applications.
Latest Patents
Colin Greineder holds a patent for "Fusion proteins and antibodies targeting human red blood cell antigens." This patent involves compositions and methods for loading cargoes onto red blood cells. The invention includes novel antibodies, fragments, fusion proteins, and other conjugates that specifically bind to red blood cells via RHCE or Band 3. He has 1 patent to his name.
Career Highlights
Colin Greineder is affiliated with the University of Pennsylvania, where he conducts his research and development. His work at this prestigious institution has allowed him to explore innovative solutions in the biomedical field.
Collaborations
Colin has collaborated with notable colleagues, including Carlos H Villa and Vladimir R Muzykantov. These partnerships have enhanced his research and contributed to the advancement of his projects.
Conclusion
Colin Greineder is a dedicated inventor whose work in red blood cell targeting technologies showcases his commitment to advancing medical science. His contributions are paving the way for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile